Literature DB >> 29491188

HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing.

Steven A Yukl1, Philipp Kaiser2, Peggy Kim2, Sushama Telwatte2, Sunil K Joshi2, Mai Vu2, Harry Lampiris2, Joseph K Wong2.   

Abstract

Latently infected CD4+ T cells are the main barrier to complete clearance of HIV infection, but it is unclear what mechanisms govern latent HIV infection in vivo. To address this question, we developed a new panel of reverse transcription droplet digital polymerase chain reaction (RT-ddPCR) assays specific for different HIV transcripts that define distinct blocks to transcription. We applied this panel of assays to CD4+ T cells freshly isolated from HIV-infected patients on suppressive antiretroviral therapy (ART) to quantify the degree to which different mechanisms inhibit HIV transcription. In addition, we measured the degree to which these transcriptional blocks could be reversed ex vivo by T cell activation (using anti-CD3/CD28 antibodies) or latency-reversing agents. We found that the main reversible block to HIV RNA transcription was not inhibition of transcriptional initiation but rather a series of blocks to proximal elongation, distal transcription/polyadenylation (completion), and multiple splicing. Cell dilution experiments suggested that these mechanisms operated in most of the HIV-infected CD4+ T cells examined. Latency-reversing agents exerted differential effects on the three blocks to HIV transcription, suggesting that these blocks may be governed by different mechanisms.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29491188      PMCID: PMC5959841          DOI: 10.1126/scitranslmed.aap9927

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  76 in total

Review 1.  Regulation of mRNA stability in mammalian cells.

Authors:  J Guhaniyogi; G Brewer
Journal:  Gene       Date:  2001-03-07       Impact factor: 3.688

2.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

3.  Transcription regulation through promoter-proximal pausing of RNA polymerase II.

Authors:  Leighton J Core; John T Lis
Journal:  Science       Date:  2008-03-28       Impact factor: 47.728

4.  A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy.

Authors:  Adam M Spivak; Adriana Andrade; Evelyn Eisele; Rebecca Hoh; Peter Bacchetti; Namandjé N Bumpus; Fatemeh Emad; Robert Buckheit; Elinore F McCance-Katz; Jun Lai; Margene Kennedy; Geetanjali Chander; Robert F Siliciano; Janet D Siliciano; Steven G Deeks
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

5.  Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines.

Authors:  R Ghose; L Y Liou; C H Herrmann; A P Rice
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  HIV-1 latency due to the site of proviral integration.

Authors:  B J Winslow; R J Pomerantz; O Bagasra; D Trono
Journal:  Virology       Date:  1993-10       Impact factor: 3.616

Review 7.  What Integration Sites Tell Us about HIV Persistence.

Authors:  Stephen H Hughes; John M Coffin
Journal:  Cell Host Microbe       Date:  2016-05-11       Impact factor: 21.023

8.  Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing.

Authors:  Yamina Bennasser; Shu-Yun Le; Monsef Benkirane; Kuan-Teh Jeang
Journal:  Immunity       Date:  2005-05       Impact factor: 31.745

9.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

Review 10.  Lost in transcription: molecular mechanisms that control HIV latency.

Authors:  Ran Taube; Matija Peterlin
Journal:  Viruses       Date:  2013-03-21       Impact factor: 5.048

View more
  117 in total

Review 1.  The multifaceted nature of HIV latency.

Authors:  Caroline Dufour; Pierre Gantner; Rémi Fromentin; Nicolas Chomont
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

2.  Histone deacetylase inhibitors induce complex host responses that contribute to differential potencies of these compounds in HIV reactivation.

Authors:  Nadejda Beliakova-Bethell; Amey Mukim; Cory H White; Savitha Deshmukh; Hosiana Abewe; Douglas D Richman; Celsa A Spina
Journal:  J Biol Chem       Date:  2019-02-11       Impact factor: 5.157

3.  IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency Reactivation.

Authors:  Dominik Hotter; Matteo Bosso; Kasper L Jønsson; Christian Krapp; Christina M Stürzel; Atze Das; Elisabeth Littwitz-Salomon; Ben Berkhout; Alina Russ; Sabine Wittmann; Thomas Gramberg; Yue Zheng; Laura J Martins; Vicente Planelles; Martin R Jakobsen; Beatrice H Hahn; Ulf Dittmer; Daniel Sauter; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2019-06-04       Impact factor: 21.023

4.  Defining stable reference genes in HIV latency reversal experiments.

Authors:  Cristina Ceriani; Gabrielle S Streeter; Kena J Lemu; Katherine S James; Simon Ghofrani; Brigitte Allard; Bonnie E Shook-Sa; David M Margolis; Nancie M Archin
Journal:  J Virol       Date:  2021-03-24       Impact factor: 5.103

5.  Disruption of latent HIV in vivo during the clearance of actinic keratosis by ingenol mebutate.

Authors:  Guochun Jiang; Emanual Maverakis; Michelle Y Cheng; Maher M Elsheikh; Claire Deleage; Gema Méndez-Lagares; Michiko Shimoda; Steven A Yukl; Dennis J Hartigan-O'Connor; George R Thompson; Jacob D Estes; Joseph K Wong; Satya Dandekar
Journal:  JCI Insight       Date:  2019-04-04

6.  Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase IIb Trial.

Authors:  Sulggi A Lee; Julian H Elliott; James McMahon; Wendy Hartogenesis; Namandje N Bumpus; Jeffrey D Lifson; Robert J Gorelick; Peter Bacchetti; Steven G Deeks; Sharon R Lewin; Radojka M Savic
Journal:  Clin Pharmacol Ther       Date:  2018-10-09       Impact factor: 6.875

7.  Latency-Reversing Agents Induce Differential Responses in Distinct Memory CD4 T Cell Subsets in Individuals on Antiretroviral Therapy.

Authors:  Marion Pardons; Rémi Fromentin; Amélie Pagliuzza; Jean-Pierre Routy; Nicolas Chomont
Journal:  Cell Rep       Date:  2019-11-26       Impact factor: 9.423

8.  Probabilistic control of HIV latency and transactivation by the Tat gene circuit.

Authors:  Youfang Cao; Xue Lei; Ruy M Ribeiro; Alan S Perelson; Jie Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-19       Impact factor: 11.205

9.  Cell-associated HIV-1 RNA predicts viral rebound and disease progression after discontinuation of temporary early ART.

Authors:  Alexander O Pasternak; Marlous L Grijsen; Ferdinand W Wit; Margreet Bakker; Suzanne Jurriaans; Jan M Prins; Ben Berkhout
Journal:  JCI Insight       Date:  2020-03-26

10.  Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral Latency.

Authors:  Todd Bradley; Guido Ferrari; Barton F Haynes; David M Margolis; Edward P Browne
Journal:  Cell Rep       Date:  2018-10-02       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.